Host biomarkers and paediatric infectious diseases: from molecular profiles to clinical application

Area of Science:

• Global Health
• Infectious Diseases
• Pediatrics

Background:

• Infectious diseases are a leading cause of mortality in children under five, especially in developing countries.
• Limited access to medical care, antibiotics, and vaccinations exacerbates this issue.
• Emerging infectious diseases (e.g., SARS, West Nile virus) and antimicrobial resistance (e.g., malaria, tuberculosis, bacterial pneumonia) present ongoing challenges in both developing and developed nations.

Purpose of the Study:

• To highlight the persistent global burden of infectious diseases in young children.
• To underscore the challenges posed by both preventable infections and emerging/resistant pathogens.
• To emphasize the need for improved healthcare access and interventions.

Main Methods:

• Literature review and synthesis of existing data on infectious disease impact.
• Analysis of mortality causes in children under five.
• Examination of factors contributing to disease prevalence and resistance.

Main Results:

• Preventable and curable infections are a primary cause of death in children under five.
• Significant disparities in healthcare access exist, particularly in developing countries.
• Modern technology has controlled some infections, but new and resistant diseases are emerging.

Conclusions:

• Infectious diseases remain a critical global health concern, especially for vulnerable young populations.
• Enhanced access to medical care, antibiotics, and vaccinations is crucial for reducing child mortality.
• Continued vigilance and research are necessary to combat emerging infectious diseases and antimicrobial resistance.